Ociperlimab represents the important development in treating self-immune disorders. The investigational antibody drug blocks neonatal-associated Fc receptor gamma-chain, a key molecule associated https://ociperlimabhumanizedigg129438.mpeblog.com/76766078/ociperlimab-this-promising-strategy-in-autoimmune-disease